These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 21545271

  • 21. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
    Espié M, Mares P, de Reilhac P, Chevallier T, Daurès JP.
    Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
    [Abstract] [Full Text] [Related]

  • 22. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women.
    Cerne JZ, Ferk P, Leskosek B, Gersak K.
    Climacteric; 2011 Aug; 14(4):458-63. PubMed ID: 21294673
    [Abstract] [Full Text] [Related]

  • 23. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005.
    Hemminki E, Kyyrönen P, Pukkala E.
    Maturitas; 2008 Dec 20; 61(4):299-304. PubMed ID: 18996655
    [Abstract] [Full Text] [Related]

  • 24. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C.
    Am J Obstet Gynecol; 2007 Apr 20; 196(4):342.e1-9. PubMed ID: 17403414
    [Abstract] [Full Text] [Related]

  • 25. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr 20; 18(100):66-7. PubMed ID: 19585723
    [Abstract] [Full Text] [Related]

  • 26. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottesen B.
    Int J Cancer; 2004 May 01; 109(5):721-7. PubMed ID: 14999781
    [Abstract] [Full Text] [Related]

  • 27. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE.
    N Engl J Med; 1995 Jun 15; 332(24):1589-93. PubMed ID: 7753136
    [Abstract] [Full Text] [Related]

  • 28. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
    Ayres de Campos D, Barros H, Martinez de Oliveira J.
    Acta Med Port; 1997 Oct 15; 10(10):697-703. PubMed ID: 9477595
    [Abstract] [Full Text] [Related]

  • 29. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H.
    Maturitas; 2005 May 16; 51(1):83-97. PubMed ID: 15883113
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A population-based cohort study of HRT use and breast cancer in southern Sweden.
    Olsson H, Bladström A, Ingvar C, Möller TR.
    Br J Cancer; 2001 Sep 01; 85(5):674-7. PubMed ID: 11531250
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L, Dell'Aniello S, Assouline S, Suissa S.
    BJOG; 2008 Jan 01; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [Abstract] [Full Text] [Related]

  • 36. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK, Chick P.
    Med J Aust; 1992 Jan 20; 156(2):124-32. PubMed ID: 1736053
    [Abstract] [Full Text] [Related]

  • 37. Population-based hormone receptor-specific incidence trends of breast cancer in Germany.
    Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, Katalinic A, Kuss O, Schmidt-Pokrzywniak A, Schubert-Fritschle G, Tillack A, Stang A.
    Maturitas; 2012 Oct 20; 73(2):152-7. PubMed ID: 22785007
    [Abstract] [Full Text] [Related]

  • 38. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort.
    Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F.
    Int J Cancer; 2005 Apr 10; 114(3):448-54. PubMed ID: 15551359
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cancer risk in women receiving estrogen-progestin replacement therapy.
    Persson I.
    Maturitas; 1996 May 10; 23 Suppl():S37-45. PubMed ID: 8865138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.